Browsing publications by Dr Ian Cowell

Newcastle AuthorsTitleYear
Dr Ian Cowell
Professor Caroline Austin
Do transcription factories and TOP2B provide a recipe for chromosome translocations in therapy-related leukemia?2012
Dr Ian Cowell
Professor Caroline Austin
Mechanism of Generation of Therapy Related Leukemia in Response to Anti-Topoisomerase II Agents2012
Dr Ian Cowell
Dr Zbyslaw Sondka
Kayleigh Smith
Ka Lee
Catriona Manville
et al.		Model for MLL translocations in therapy-related leukemia involving topoisomerase II beta-mediated DNA strand breaks and gene proximity2012
Dr Kay Padget
Hannah Curtis
Dr Ian Cowell
Dr Zbyslaw Sondka
Dr Nick Morris
et al.		MRE11 facilitates the removal of human topoisomerase II complexes from genomic DNA2012
Dr Ian Cowell
Dr Michael Tilby
Professor Caroline Austin
An overview of the visualisation and quantitation of low and high MW DNA adducts using the trapped in agarose DNA immunostaining (TARDIS) assay2011
Dr Ian Cowell
Dr Nikolaos Papageorgiou
Dr Kay Padget
Professor Caroline Austin
Histone deacetylase inhibition redistributes topoisomerase IIβ from heterochromatin to euchromatin2011
Dr Nicola Sunter
Dr Ian Cowell
Dr Elaine Willmore
Gary Watters
Professor Caroline Austin
et al.		Role of Topoisomerase IIbeta in DNA Damage Response following IR and Etoposide2010
Professor Caroline Austin
Dr Ian Cowell
Dr Michael Tilby
Visualisation and quantitation of DNA adducts using the Trapped in Agarose DNA immunostaining (TARDIS) assay2010
Dr Elaine Willmore
Dr Sarah Johnson
Dr Tryfonia Mainou-Fowler
Professor Graham Jackson
Dr Celine Cano
et al.		DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia2008
Dr Ian Cowell
Professor Caroline Austin
NK314, a topoisomerase II inhibitor that specifically targets the alpha isoform2008
1234